G6PC3 and glioblastoma: In this study, we assessed the transcript levels and the specific roles of the G6P sensing components G6PC3, SLC37A2, and SLC37A4, all found increased in clinical GBM tissues (Figure 1) and correlated with decreased overall patient survival (Figure 2).